Search research articles
Contact Us
Filters
Showing results (101-110 of 108) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 108 results.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology
|
November 9, 2000
Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes
P V Woolley, S M Gollin, W Riskalla, et al.
Cancer Treatment Reports
|
March 1, 1981
CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung
R J Cambareri, F P Smith, J S Macdonald, et al.
Cancer
|
October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung
J Y Killen, E P Mitchell, D F Hoth, et al.
Investigational New Drugs
|
January 1, 1996
A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma
P V Woolley, C J Schultz, G I Rodriguez, et al.
Annals of Internal Medicine
|
October 1, 1980
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer
J S MacDonald, P S Schein, P V Woolley, et al.
Cancer Treatment Reports
|
June 1, 1986
Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach
E L Cazap, C Gisselbrecht, F P Smith, et al.
Cancer Treatment Reports
|
January 1, 1983
Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck
D J Perry, S M Crain, M D Weltz, et al.
Cancer Treatment Reports
|
July 1, 1984
Phase II trial of PCNU in advanced renal cell carcinoma and malignant melanoma
J H Harvey, F P Smith, M W Bowers, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 108) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 108 results.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology
|
November 9, 2000
Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes
P V Woolley, S M Gollin, W Riskalla, et al.
Cancer Treatment Reports
|
March 1, 1981
CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung
R J Cambareri, F P Smith, J S Macdonald, et al.
Cancer
|
October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung
J Y Killen, E P Mitchell, D F Hoth, et al.
Investigational New Drugs
|
January 1, 1996
A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma
P V Woolley, C J Schultz, G I Rodriguez, et al.
Annals of Internal Medicine
|
October 1, 1980
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer
J S MacDonald, P S Schein, P V Woolley, et al.
Cancer Treatment Reports
|
June 1, 1986
Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach
E L Cazap, C Gisselbrecht, F P Smith, et al.
Cancer Treatment Reports
|
January 1, 1983
Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck
D J Perry, S M Crain, M D Weltz, et al.
Cancer Treatment Reports
|
July 1, 1984
Phase II trial of PCNU in advanced renal cell carcinoma and malignant melanoma
J H Harvey, F P Smith, M W Bowers, et al.
Page
of 11